Global Anthrax Vaccines Market Insights and Forecast to 2028

Publisher Name :
Date: 28-Jan-2022
No. of pages: 128
Inquire Before Buying

Anthrax Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anthrax Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Live Vaccines

- Cell free PA Vaccines

Segment by Application

- Human Use

- Animal Use

By Company

- Emergent BioSolutions

- Merial

- Merck

- Zoetis

- Bayer Sanidad Animal

- Colorado Serum

- PharmAthene

- Tiankang

- Biogénesis-Bago

- CAVAC

- Rosenbusch

- Agrovet

- Vecol

- CVCRI

- IVPM

- Prondil

- CDV

- Indian Immunologicals

- Botswana Vaccine Institute

- Ceva Santé Animale

- Intervac

- JOVAC

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Anthrax Vaccines Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Anthrax Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Anthrax Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Live Vaccines
1.2.3 Cell free PA Vaccines
1.3 Market by Application
1.3.1 Global Anthrax Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Human Use
1.3.3 Animal Use
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anthrax Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Anthrax Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Anthrax Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anthrax Vaccines Sales by Region
2.4.1 Global Anthrax Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Anthrax Vaccines by Region (2023-2028)
2.5 Global Anthrax Vaccines Revenue by Region
2.5.1 Global Anthrax Vaccines Revenue by Region (2017-2022)
2.5.2 Global Anthrax Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anthrax Vaccines Sales by Manufacturers
3.1.1 Global Top Anthrax Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Anthrax Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anthrax Vaccines in 2021
3.2 Global Anthrax Vaccines Revenue by Manufacturers
3.2.1 Global Anthrax Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Anthrax Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anthrax Vaccines Revenue in 2021
3.3 Global Anthrax Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anthrax Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anthrax Vaccines Sales by Type
4.1.1 Global Anthrax Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Anthrax Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Anthrax Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Anthrax Vaccines Revenue by Type
4.2.1 Global Anthrax Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Anthrax Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anthrax Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Anthrax Vaccines Price by Type
4.3.1 Global Anthrax Vaccines Price by Type (2017-2022)
4.3.2 Global Anthrax Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anthrax Vaccines Sales by Application
5.1.1 Global Anthrax Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Anthrax Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Anthrax Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Anthrax Vaccines Revenue by Application
5.2.1 Global Anthrax Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Anthrax Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anthrax Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Anthrax Vaccines Price by Application
5.3.1 Global Anthrax Vaccines Price by Application (2017-2022)
5.3.2 Global Anthrax Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anthrax Vaccines Market Size by Type
6.1.1 North America Anthrax Vaccines Sales by Type (2017-2028)
6.1.2 North America Anthrax Vaccines Revenue by Type (2017-2028)
6.2 North America Anthrax Vaccines Market Size by Application
6.2.1 North America Anthrax Vaccines Sales by Application (2017-2028)
6.2.2 North America Anthrax Vaccines Revenue by Application (2017-2028)
6.3 North America Anthrax Vaccines Market Size by Country
6.3.1 North America Anthrax Vaccines Sales by Country (2017-2028)
6.3.2 North America Anthrax Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anthrax Vaccines Market Size by Type
7.1.1 Europe Anthrax Vaccines Sales by Type (2017-2028)
7.1.2 Europe Anthrax Vaccines Revenue by Type (2017-2028)
7.2 Europe Anthrax Vaccines Market Size by Application
7.2.1 Europe Anthrax Vaccines Sales by Application (2017-2028)
7.2.2 Europe Anthrax Vaccines Revenue by Application (2017-2028)
7.3 Europe Anthrax Vaccines Market Size by Country
7.3.1 Europe Anthrax Vaccines Sales by Country (2017-2028)
7.3.2 Europe Anthrax Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anthrax Vaccines Market Size by Type
8.1.1 Asia Pacific Anthrax Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Anthrax Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Anthrax Vaccines Market Size by Application
8.2.1 Asia Pacific Anthrax Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Anthrax Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Anthrax Vaccines Market Size by Region
8.3.1 Asia Pacific Anthrax Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Anthrax Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Anthrax Vaccines Market Size by Type
9.1.1 Latin America Anthrax Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Anthrax Vaccines Revenue by Type (2017-2028)
9.2 Latin America Anthrax Vaccines Market Size by Application
9.2.1 Latin America Anthrax Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Anthrax Vaccines Revenue by Application (2017-2028)
9.3 Latin America Anthrax Vaccines Market Size by Country
9.3.1 Latin America Anthrax Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Anthrax Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anthrax Vaccines Market Size by Type
10.1.1 Middle East and Africa Anthrax Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anthrax Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Anthrax Vaccines Market Size by Application
10.2.1 Middle East and Africa Anthrax Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anthrax Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Anthrax Vaccines Market Size by Country
10.3.1 Middle East and Africa Anthrax Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anthrax Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Emergent BioSolutions
11.1.1 Emergent BioSolutions Corporation Information
11.1.2 Emergent BioSolutions Overview
11.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Emergent BioSolutions Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Emergent BioSolutions Recent Developments
11.2 Merial
11.2.1 Merial Corporation Information
11.2.2 Merial Overview
11.2.3 Merial Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merial Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merial Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Zoetis
11.4.1 Zoetis Corporation Information
11.4.2 Zoetis Overview
11.4.3 Zoetis Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Zoetis Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Zoetis Recent Developments
11.5 Bayer Sanidad Animal
11.5.1 Bayer Sanidad Animal Corporation Information
11.5.2 Bayer Sanidad Animal Overview
11.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bayer Sanidad Animal Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bayer Sanidad Animal Recent Developments
11.6 Colorado Serum
11.6.1 Colorado Serum Corporation Information
11.6.2 Colorado Serum Overview
11.6.3 Colorado Serum Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Colorado Serum Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Colorado Serum Recent Developments
11.7 PharmAthene
11.7.1 PharmAthene Corporation Information
11.7.2 PharmAthene Overview
11.7.3 PharmAthene Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 PharmAthene Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 PharmAthene Recent Developments
11.8 Tiankang
11.8.1 Tiankang Corporation Information
11.8.2 Tiankang Overview
11.8.3 Tiankang Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Tiankang Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Tiankang Recent Developments
11.9 Biogénesis-Bago
11.9.1 Biogénesis-Bago Corporation Information
11.9.2 Biogénesis-Bago Overview
11.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Biogénesis-Bago Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Biogénesis-Bago Recent Developments
11.10 CAVAC
11.10.1 CAVAC Corporation Information
11.10.2 CAVAC Overview
11.10.3 CAVAC Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 CAVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CAVAC Recent Developments
11.11 Rosenbusch
11.11.1 Rosenbusch Corporation Information
11.11.2 Rosenbusch Overview
11.11.3 Rosenbusch Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Rosenbusch Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Rosenbusch Recent Developments
11.12 Agrovet
11.12.1 Agrovet Corporation Information
11.12.2 Agrovet Overview
11.12.3 Agrovet Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Agrovet Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Agrovet Recent Developments
11.13 Vecol
11.13.1 Vecol Corporation Information
11.13.2 Vecol Overview
11.13.3 Vecol Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Vecol Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Vecol Recent Developments
11.14 CVCRI
11.14.1 CVCRI Corporation Information
11.14.2 CVCRI Overview
11.14.3 CVCRI Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 CVCRI Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 CVCRI Recent Developments
11.15 IVPM
11.15.1 IVPM Corporation Information
11.15.2 IVPM Overview
11.15.3 IVPM Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 IVPM Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 IVPM Recent Developments
11.16 Prondil
11.16.1 Prondil Corporation Information
11.16.2 Prondil Overview
11.16.3 Prondil Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Prondil Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Prondil Recent Developments
11.17 CDV
11.17.1 CDV Corporation Information
11.17.2 CDV Overview
11.17.3 CDV Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 CDV Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 CDV Recent Developments
11.18 Indian Immunologicals
11.18.1 Indian Immunologicals Corporation Information
11.18.2 Indian Immunologicals Overview
11.18.3 Indian Immunologicals Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Indian Immunologicals Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Indian Immunologicals Recent Developments
11.19 Botswana Vaccine Institute
11.19.1 Botswana Vaccine Institute Corporation Information
11.19.2 Botswana Vaccine Institute Overview
11.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Botswana Vaccine Institute Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Botswana Vaccine Institute Recent Developments
11.20 Ceva Santé Animale
11.20.1 Ceva Santé Animale Corporation Information
11.20.2 Ceva Santé Animale Overview
11.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Ceva Santé Animale Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Ceva Santé Animale Recent Developments
11.21 Intervac
11.21.1 Intervac Corporation Information
11.21.2 Intervac Overview
11.21.3 Intervac Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Intervac Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Intervac Recent Developments
11.22 JOVAC
11.22.1 JOVAC Corporation Information
11.22.2 JOVAC Overview
11.22.3 JOVAC Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 JOVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 JOVAC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anthrax Vaccines Industry Chain Analysis
12.2 Anthrax Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anthrax Vaccines Production Mode & Process
12.4 Anthrax Vaccines Sales and Marketing
12.4.1 Anthrax Vaccines Sales Channels
12.4.2 Anthrax Vaccines Distributors
12.5 Anthrax Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anthrax Vaccines Industry Trends
13.2 Anthrax Vaccines Market Drivers
13.3 Anthrax Vaccines Market Challenges
13.4 Anthrax Vaccines Market Restraints
14 Key Findings in The Global Anthrax Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Anthrax Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Live Vaccines
Table 3. Major Manufacturers of Cell free PA Vaccines
Table 4. Global Anthrax Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Anthrax Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Anthrax Vaccines Sales by Region (2017-2022) & (M Doses)
Table 7. Global Anthrax Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Anthrax Vaccines Sales by Region (2023-2028) & (M Doses)
Table 9. Global Anthrax Vaccines Sales Market Share by Region (2023-2028)
Table 10. Global Anthrax Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Anthrax Vaccines Revenue Market Share by Region (2017-2022)
Table 12. Global Anthrax Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Anthrax Vaccines Revenue Market Share by Region (2023-2028)
Table 14. Global Anthrax Vaccines Sales by Manufacturers (2017-2022) & (M Doses)
Table 15. Global Anthrax Vaccines Sales Share by Manufacturers (2017-2022)
Table 16. Global Anthrax Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Anthrax Vaccines Revenue Share by Manufacturers (2017-2022)
Table 18. Anthrax Vaccines Price by Manufacturers (2017-2022) &(USD/Dose)
Table 19. Global Anthrax Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Anthrax Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthrax Vaccines as of 2021)
Table 21. Anthrax Vaccines Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Anthrax Vaccines Product Offered
Table 23. Date of Manufacturers Enter into Anthrax Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 26. Global Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
Table 27. Global Anthrax Vaccines Sales Share by Type (2017-2022)
Table 28. Global Anthrax Vaccines Sales Share by Type (2023-2028)
Table 29. Global Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Anthrax Vaccines Revenue Share by Type (2017-2022)
Table 32. Global Anthrax Vaccines Revenue Share by Type (2023-2028)
Table 33. Anthrax Vaccines Price by Type (2017-2022) & (USD/Dose)
Table 34. Global Anthrax Vaccines Price Forecast by Type (2023-2028) & (USD/Dose)
Table 35. Global Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 36. Global Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
Table 37. Global Anthrax Vaccines Sales Share by Application (2017-2022)
Table 38. Global Anthrax Vaccines Sales Share by Application (2023-2028)
Table 39. Global Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Anthrax Vaccines Revenue Share by Application (2017-2022)
Table 42. Global Anthrax Vaccines Revenue Share by Application (2023-2028)
Table 43. Anthrax Vaccines Price by Application (2017-2022) & (USD/Dose)
Table 44. Global Anthrax Vaccines Price Forecast by Application (2023-2028) & (USD/Dose)
Table 45. North America Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 46. North America Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
Table 47. North America Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 50. North America Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
Table 51. North America Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
Table 54. North America Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
Table 55. North America Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 58. Europe Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
Table 59. Europe Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 62. Europe Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
Table 63. Europe Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
Table 66. Europe Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
Table 67. Europe Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 70. Asia Pacific Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
Table 71. Asia Pacific Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 74. Asia Pacific Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
Table 75. Asia Pacific Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Anthrax Vaccines Sales by Region (2017-2022) & (M Doses)
Table 78. Asia Pacific Anthrax Vaccines Sales by Region (2023-2028) & (M Doses)
Table 79. Asia Pacific Anthrax Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Anthrax Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 82. Latin America Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
Table 83. Latin America Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 86. Latin America Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
Table 87. Latin America Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
Table 90. Latin America Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
Table 91. Latin America Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 94. Middle East and Africa Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
Table 95. Middle East and Africa Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 98. Middle East and Africa Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
Table 99. Middle East and Africa Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
Table 102. Middle East and Africa Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
Table 103. Middle East and Africa Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 105. Emergent BioSolutions Corporation Information
Table 106. Emergent BioSolutions Description and Major Businesses
Table 107. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 108. Emergent BioSolutions Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Emergent BioSolutions Recent Developments
Table 110. Merial Corporation Information
Table 111. Merial Description and Major Businesses
Table 112. Merial Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. Merial Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Merial Recent Developments
Table 115. Merck Corporation Information
Table 116. Merck Description and Major Businesses
Table 117. Merck Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. Merck Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Merck Recent Developments
Table 120. Zoetis Corporation Information
Table 121. Zoetis Description and Major Businesses
Table 122. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 123. Zoetis Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Zoetis Recent Developments
Table 125. Bayer Sanidad Animal Corporation Information
Table 126. Bayer Sanidad Animal Description and Major Businesses
Table 127. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 128. Bayer Sanidad Animal Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Bayer Sanidad Animal Recent Developments
Table 130. Colorado Serum Corporation Information
Table 131. Colorado Serum Description and Major Businesses
Table 132. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 133. Colorado Serum Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Colorado Serum Recent Developments
Table 135. PharmAthene Corporation Information
Table 136. PharmAthene Description and Major Businesses
Table 137. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 138. PharmAthene Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. PharmAthene Recent Developments
Table 140. Tiankang Corporation Information
Table 141. Tiankang Description and Major Businesses
Table 142. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 143. Tiankang Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Tiankang Recent Developments
Table 145. Biogénesis-Bago Corporation Information
Table 146. Biogénesis-Bago Description and Major Businesses
Table 147. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 148. Biogénesis-Bago Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Biogénesis-Bago Recent Developments
Table 150. CAVAC Corporation Information
Table 151. CAVAC Description and Major Businesses
Table 152. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 153. CAVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. CAVAC Recent Developments
Table 155. Rosenbusch Corporation Information
Table 156. Rosenbusch Description and Major Businesses
Table 157. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 158. Rosenbusch Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Rosenbusch Recent Developments
Table 160. Agrovet Corporation Information
Table 161. Agrovet Description and Major Businesses
Table 162. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 163. Agrovet Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Agrovet Recent Developments
Table 165. Vecol Corporation Information
Table 166. Vecol Description and Major Businesses
Table 167. Vecol Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 168. Vecol Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Vecol Recent Developments
Table 170. CVCRI Corporation Information
Table 171. CVCRI Description and Major Businesses
Table 172. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 173. CVCRI Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. CVCRI Recent Developments
Table 175. IVPM Corporation Information
Table 176. IVPM Description and Major Businesses
Table 177. IVPM Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 178. IVPM Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. IVPM Recent Developments
Table 180. Prondil Corporation Information
Table 181. Prondil Description and Major Businesses
Table 182. Prondil Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 183. Prondil Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Prondil Recent Developments
Table 185. CDV Corporation Information
Table 186. CDV Description and Major Businesses
Table 187. CDV Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 188. CDV Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. CDV Recent Developments
Table 190. Indian Immunologicals Corporation Information
Table 191. Indian Immunologicals Description and Major Businesses
Table 192. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 193. Indian Immunologicals Anthrax Vaccines Product Mode
  • Gatifloxacin Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type
    Published: 14-May-2022        Price: US 3500 Onwards        Pages: 81
    This report describes the global market size of Gatifloxacin from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027. For geography segment, regional supply, demand, major players, price is presented from 2017 to 2027. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also included su......
  • Global and United States Valganciclovir Market Report & Forecast 2022-2028
    Published: 14-May-2022        Price: US 4350 Onwards        Pages: 77
    Valganciclovir market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Valganciclovir market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Valganciclovir market size by players, by Type and by......
  • Global and United States Meningitis Vaccine Market Report & Forecast 2022-2028
    Published: 14-May-2022        Price: US 4350 Onwards        Pages: 95
    Meningitis Vaccine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Meningitis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Meningitis Vaccine market size by players, by......
  • Global and United States Analgesics Market Report & Forecast 2022-2028
    Published: 14-May-2022        Price: US 4350 Onwards        Pages: 103
    Analgesics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Analgesics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Analgesics market size by players, by Type and by Application......
  • Global and United States Viral Vaccines Market Report & Forecast 2022-2028
    Published: 14-May-2022        Price: US 4350 Onwards        Pages: 106
    Viral Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Viral Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Viral Vaccines market size by players, by Type and by......
  • (Post-pandemic Era) - Global Zika Virus Market Segment Research Report 2022
    Published: 13-May-2022        Price: US 2950 Onwards        Pages: 103
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • (Post-pandemic Era) - Global Therapeutic Vaccines Market Segment Research Report 2022
    Published: 13-May-2022        Price: US 2950 Onwards        Pages: 100
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • (Post-pandemic Era) - Global Solid Organ Transplant Immunosuppressant Market Segment Research Report 2022
    Published: 13-May-2022        Price: US 2950 Onwards        Pages: 114
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • (Post-pandemic Era) - Global Orphan Drugs Market Segment Research Report 2022
    Published: 13-May-2022        Price: US 2950 Onwards        Pages: 117
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs